RxDoctor Payments DataLook up a doctor →

Shari Brazinsky

Pulmonary Disease · San Diego, CANPI 1245339340

Payments from drug & device makers

$522,000in general payments, 2019–2025

Across 579 payments — averaging $901.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$254K
  • AstraZeneca$83K
  • Insmed, Inc.$52K
  • Chiesi USA, Inc.$45K
  • Roche Products Limited$35K
  • Sanofi US Services Inc.$18K
  • plus $34K from 39 others

What the payments were for

  • Consulting fees$6451%
  • Speaking & faculty fees$68,82384%
  • Travel & lodging$4,5195%
  • Food & beverage$8,02810%
  • Education$1710%
  • Gifts$280%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$522,000 in reported general payments places this provider in the 95th percentile of 1,261 pulmonary disease providers in California.

See all pulmonary disease providers in California

Other pulmonary disease in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →